Jianjian Gong works in Heart Failure & Transplant affiliated with Novartis (Switzerland).
Jianjian Gong is an Executive Director of Biostatistics at Novartis in Basel, Switzerland. He contributes to the statistical design and analysis of clinical trials for cardiovascular drugs, particularly in heart failure management. His research has been featured in studies evaluating treatments like sacubitril/valsartan.
52 pubs · 14,656 cites · h-index 27
PhD
University of Wisconsin–Madison
1996
Executive Director, Biostatistics
Novartis (Switzerland) · 2011 - Present